{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:01:51Z","timestamp":1753891311058,"version":"3.41.2"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Anti-leucine-rich glioma-inactivated 1 (LGI1) encephalitis is the second most common cause of autoimmune encephalitis and is characterized by cognitive impairment, psychiatric disorders, and faciobrachial dystonic seizures. In recent decades, literature reports have expanded the phenotypic spectrum associated with the LGI1 autoantibody. The present report describes the case of a 58-year-old man who presented with repetitive unilateral hyperhidrosis of the body and arm as an initial symptom and gradually developed psychiatric symptoms, involuntary movements of the face and arms, and progressive cognitive decline. Anti-LGI1 antibodies were positive in both the serum and cerebrospinal fluid at approximately 2 months after symptom onset, and the patient was, therefore, diagnosed with anti-LGI1 encephalitis. His symptoms, namely hyperhidrosis and involuntary movements, were not relieved by antiepileptic drug treatment, but responded favorably to high-dose steroid therapy and intravenous immunoglobulin. We interpreted the repetitive unilateral hyperhidrosis as possible epilepsy. Based on this case, unilateral hyperhidrosis of the body and arm as a rare neurological presentation can be added to the phenotypic spectrum of anti-LGI1 encephalitis, and early recognition of this manifestation might support timely diagnosis and treatment.<\/jats:p>","DOI":"10.3389\/fimmu.2022.986853","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T07:31:21Z","timestamp":1663918281000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Case Report: Paroxysmal hyperhidrosis as an initial symptom in a patient with anti-LGI1 encephalitis"],"prefix":"10.3389","volume":"13","author":[{"given":"Tingting","family":"Qiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanlan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingzhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2018.10.014","article-title":"Prognosticating autoimmune encephalitis: A systematic review","volume":"94","author":"Broadley","year":"2019","journal-title":"J Autoimmun"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.621599","article-title":"Neuronal surface antibody-medicated autoimmune encephalitis (Limbic encephalitis) in China: A multiple-center, retrospective study","volume":"12","author":"Shan","year":"2021","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70137-X","article-title":"Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series","volume":"9","author":"Lai","year":"2010","journal-title":"Lancet Neurol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/epi.16807","article-title":"Seizures in autoimmune encephalitis-a systematic review and quantitative synthesis","volume":"62","author":"Yeshokumar","year":"2021","journal-title":"Epilepsia"},{"key":"B5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/ana.24979","article-title":"Expanded phenotypes and outcomes among 256 LGI1\/CASPR2-IgG-positive patients","volume":"82","author":"Gadoth","year":"2017","journal-title":"Ann Neurol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.803752","article-title":"Clinical features and early recognition of 242 cases of autoimmune encephalitis","volume":"12","author":"Yang","year":"2022","journal-title":"Front Neurol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003173","article-title":"Anti-LGI1 encephalitis: Clinical syndrome and long-term follow-up","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.07.018","article-title":"From VGKC to LGI1 and Caspr2 encephalitis: The evolution of a disease entity over time","volume":"15","author":"Van Sonderen","year":"2016","journal-title":"Autoimmun Rev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2015-313000","article-title":"Emerging psychiatric syndromes associated with antivoltage-gated potassium channel complex antibodies","volume":"87","author":"Pr\u00fcss","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.813174","article-title":"Acute symptomatic seizures and risk of epilepsy in autoimmune encephalitis: A retrospective cohort study","volume":"13","author":"Zhong","year":"2021","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51137","article-title":"Seizures and risk of epilepsy in anti-NMDAR, anti-LGI1, and anti-GABABR encephalitis","volume":"7","author":"Shen","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00010.2016","article-title":"Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system","volume":"97","author":"Dalmau","year":"2017","journal-title":"Physiol Rev"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.845365","article-title":"Risk factor for mortality in anti-NMDAR, anti-LGI1, and anti-GABABR encephalitis","volume":"13","author":"Zhong","year":"2022","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103074","article-title":"Contemporary advances in antibody-mediated encephalitis: anti-LGI1 and anti-Caspr2 antibody (Ab)-mediated encephalitides","volume":"21","author":"Seery","year":"2022","journal-title":"Autoimmun Rev"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww012","article-title":"Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis","volume":"139","author":"Navarro","year":"2016","journal-title":"Brain"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1684\/epd.2017.0936","article-title":"Seizure semiology of anti-LGI1 antibody encephalitis","volume":"19","author":"Beimer","year":"2017","journal-title":"Epileptic Disord"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.5607\/en.2013.22.4.337","article-title":"Anti-LGI1 limbic encephalitis presented with atypical manifestations","volume":"22","author":"Lee","year":"2013","journal-title":"Exp Neurobiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2021.01.003","article-title":"Orbitofrontal syndrome and \u201cgoosebumps\u201d-a new manifestation of autoimmune epilepsy in anti-LGI1 encephalitis","volume":"86","author":"Dias","year":"2021","journal-title":"Seizure"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00061","article-title":"Pilomotor seizures in a patient with LGI1 encephalitis","volume":"11","author":"Yang","year":"2020","journal-title":"Front Neurol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2018.08.019","article-title":"Clinical and electrographic characteristics of seizures in LGI1-antibody encephalitis","volume":"88","author":"Li","year":"2018","journal-title":"Epilepsy Behav"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/ane.13503","article-title":"Neurofunctional outcomes in patients with anti-leucine-rich glioma inactivated 1 encephalitis","author":"Chen","year":"2021","journal-title":"Acta Neurol Scand"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.791014","article-title":"Clinical features and therapeutic effects of anti-leucine-rich glioma inactivated 1 encephalitis: A systematic review","volume":"12","author":"Teng","year":"2022","journal-title":"Front Neurol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/17562864211073203","article-title":"Clinical characteristics, long-term functional outcomes and relapse of anti-LGI1\/Caspr2 encephalitis: A prospective cohort study in Western China","volume":"15","author":"Guo","year":"2022","journal-title":"Ther Adv Neurol Disord"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.986853\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T07:31:24Z","timestamp":1663918284000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.986853\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":23,"alternative-id":["10.3389\/fimmu.2022.986853"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.986853","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2022,9,23]]},"article-number":"986853"}}